Rosiello Robert L. 4
4 · Omega Therapeutics, Inc. · Filed Oct 4, 2024
Insider Transaction Report
Form 4
Rosiello Robert L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-02+50,000→ 50,000 totalExercise: $1.09Exp: 2034-10-01→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.